insider24.ch
Company / strategic investorRegistered location :GenevaGroup :RELIEF THERAPEUTICS Holding SA

Relief Therapeutics International SADeclared Swiss shareholdings

Relief Therapeutics International SA: 0 Swiss companies with a declared holding.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
—
Swiss companies held
0
Largest position
—
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
…

Declared Swiss portfolio

Latest declared rate per company

No active declared position.

How to read these figures?

Rates come from the 29 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure2 controlled by

Controlled by

Group entities that file jointly with this shareholder as its head.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 0

90 days · Downward crossings

0

visible history: 0

First disclosure: —Last disclosure: —

Latest shareholding disclosures

SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

59.322%Voting rights sold04.03.2026
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

36.975%Voting rights sold04.02.2026
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

32.796%Voting rights sold20.01.2026
Show 22 older disclosures
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

27.322%Voting rights sold18.12.2025
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

76.56%Voting rights sold05.05.2023
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

54.958%Voting rights sold22.02.2023
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

47.217%Voting rights sold22.12.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

57.002%Voting rights sold14.12.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

59.351%Voting rights sold10.11.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

65.491%Voting rights sold25.10.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

67.543%Voting rights sold13.10.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

58.283%Voting rights sold08.07.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

58.283%Voting rights sold08.07.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

59.772%Voting rights sold05.07.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

37.039%Voting rights sold04.05.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

28.136%Voting rights sold04.12.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

22.57%Voting rights sold04.11.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

13.065%Voting rights acquired04.09.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

22.726%Voting rights acquired31.07.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

19.641%Voting rights acquired31.07.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

13.318%Voting rights acquired31.07.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

29.41%Voting rights acquired27.07.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

21.104%Voting rights sold07.05.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

9.904%Voting rights sold16.03.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

Relief Therapeutics International SA · Single shareholder

8.781%Voting rights sold09.03.2021

insider24.ch

Follow Relief Therapeutics International SA’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Common questions

Which Swiss companies are in Relief Therapeutics International SA’s disclosed portfolio?

No active holding identified in available disclosures.

What is Relief Therapeutics International SA’s latest disclosure?

The latest available disclosure was published on 04.03.2026 and concerns MindMaze Therapeutics Holding SA. Threshold disclosures do not describe every purchase or sale.

Explore further

Recent insider purchases

What are insiders doing at companies disclosed by this shareholder?

All purchases this week

Insider barometer

Compare insider purchases and sales across the Swiss stock exchange over 30 days.

View the Swiss barometer

These signals are not investment advice.